Axsome Therapeutics, Inc. Financial Ratios — AXSM Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-79.99	-151.19	-350.78	-76.08	-70.36	-201.51	-298.97	-159.21	-231.63	-252.11
Return on Assets (%)	- -	-245.74	-47.09	-62.33	-78.47	-121.59	-57.94	-50.6	-95.21	-89.27	-52.02	-49.66	-29.11
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	89.61	90.37	91.37	92.56
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-343.94	-65.07	-63.39	-25.09
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-352.74	-67.59	-65.45	-26.51
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-373.99	-88.06	-74.45	-28.77
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-373.99	-88.41	-74.47	-28.69
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-373.99	-88.41	-74.47	-28.69
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-79.99	-151.19	-350.78	-76.08	-70.36	-201.51	-298.97	-159.21	-231.63	-252.11

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	4	- -	10	10	7	20	50	50	95	186	193	218
ST Debt	4	- -	- -	- -	3	3	3	1	1	- -	1	3	73
LT Debt	- -	4	- -	9	7	4	17	49	49	94	185	190	145
Total Debt/EBITDA	-2.08	-0.82	- -	-0.36	-0.37	-0.21	-0.3	-0.51	-0.4	-0.55	-1.06	-0.79	-1.36
Net Debt/EBITDA	-0.94	-0.34	5.23	0.99	0.9	0.22	2.98	1.37	0.3	0.62	1.18	0.55	0.84
Total Debt/EBIT	-2.08	-0.82	- -	-0.36	-0.37	-0.21	-0.3	-0.51	-0.4	-0.54	-1.02	-0.76	-1.29
Net Debt/EBIT	-0.94	-0.34	5.22	0.99	0.89	0.22	2.98	1.37	0.3	0.6	1.14	0.53	0.8
EBITDA to Interest Expense	-5.62	-2.46	-12.49	-204.26	-20.08	-28.9	-54.11	-38.59	-21.88	-23.46	-27.29	-37.22	-24.43
EBITDA-CapEx/Interest Expense	-5.62	-2.46	-12.52	-205.05	-20.09	-28.93	-54.12	-38.61	-21.93	-23.56	-27.38	-37.26	-24.5
EBIT to Interest Expense	-5.62	-2.46	-12.49	-204.41	-20.11	-28.94	-54.14	-38.62	-21.89	-24.06	-28.34	-38.43	-25.81
Interest Expense	- -	2	1	- -	1	1	1	3	6	7	6	7	7
Common Equity/Total Assets	-96.68	-114.94	94.64	56.45	47.02	6.1	81.03	61.13	17.81	33.05	32.47	10.03	12.8
Long-Term Debt/Equity (%)	- -	- -	- -	43.9	39.86	385.9	9.7	42.98	314.07	86.04	96.93	332.72	164.37
Long-Term Debt/Capital (%)	- -	346.9	- -	30.25	25	46.11	8.72	29.83	75.13	46.15	49.05	75.89	47.37
Long-Term Debt/Total Assets (%)	- -	159.4	- -	24.78	18.74	23.53	7.86	26.27	55.92	28.44	31.47	33.37	21.04
Total Debt/Equity (%)	-188.66	-139.98	- -	45.15	59.41	736.82	11.15	44.05	318.04	86.43	97.59	338.43	247.03
Total Debt/Capital (%)	212.79	350.14	- -	31.11	37.27	88.05	10.03	30.58	76.08	46.36	49.39	77.19	71.18
Total Debt/Total Assets (%)	182.4	160.89	- -	25.49	27.93	44.94	9.04	26.93	56.63	28.56	31.68	33.94	31.62
Net Debt to Equity	-85.7	-58.24	-103.43	-124.6	-144.1	-752.51	-111.92	-119.12	-239.17	-97.29	-108.98	-236.15	-153.11
Net Debt/Capital (%)	-599.34	-139.44	3,017.35	506.44	326.78	115.33	938.72	679.15	176.9	-3,136.64	2,353.27	205.93	818.08
EBITDA	-2	-5	-9	-27	-27	-33	-67	-99	-125	-172	-176	-244	-160
EBITDA-CapEx	-2	-5	-9	-27	-27	-33	-67	-99	-125	-173	-177	-245	-161
Operating Income (Loss)	-2	-5	-9	-27	-27	-33	-67	-99	-125	-177	-183	-252	-169

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.51	2.69	18.25	5.11	2.79	1.29	8.98	7.85	3.75	2.08	2.78	1.37	0.85
Current Ratio	0.51	2.82	18.63	5.3	2.9	1.41	9	7.85	3.75	2.54	3.63	2.11	1.55
Quick Ratio	0.51	2.69	18.25	5.11	2.79	1.29	8.98	7.85	3.75	2.47	3.46	1.99	1.44
CFO/Avg Current Liab	- -	-1.8	-4.13	-4.34	-2.74	-2.61	-2.63	-3.27	-4.65	-1.95	-1.23	-0.7	-0.31
Common Equity/Total Assets	-96.68	-114.94	94.64	56.45	47.02	6.1	81.03	61.13	17.81	33.05	32.47	10.03	12.8
Long-Term Debt/Equity (%)	- -	- -	- -	43.9	39.86	385.9	9.7	42.98	314.07	86.04	96.93	332.72	164.37
Long-Term Debt/Capital (%)	- -	346.9	- -	30.25	25	46.11	8.72	29.83	75.13	46.15	49.05	75.89	47.37
Long-Term Debt/Total Assets (%)	- -	159.4	- -	24.78	18.74	23.53	7.86	26.27	55.92	28.44	31.47	33.37	21.04
Total Debt/Equity (%)	-188.66	-139.98	- -	45.15	59.41	736.82	11.15	44.05	318.04	86.43	97.59	338.43	247.03
Total Debt/Capital (%)	212.79	350.14	- -	31.11	37.27	88.05	10.03	30.58	76.08	46.36	49.39	77.19	71.18
Total Debt/Total Assets (%)	182.4	160.89	- -	25.49	27.93	44.94	9.04	26.93	56.63	28.56	31.68	33.94	31.62
CFO/Total Liabilities	-39.54	-76.75	-282.65	-127.88	-140.52	-208.11	-110.87	-108.45	-149.99	-52.5	-36.52	-25.11	-15.53
CFO/CapEx	- -	- -	-368.36	-203.53	-2,674.44	-919.19	-2,876.69	-1,709.63	-351.38	-165.97	-249.28	-475.59	-194.59
Altman's Z-Score	-5.54	-9.87	40.4	1.55	-0.19	-12.92	53.7	22.44	1.53	4.53	3.66	1.47	6.92

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.65	4.08	3.26	3.48
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	137.5	89.37	112.06	104.75
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.41	2.68	2.16	2.17
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	151.67	136.22	169.15	167.86
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.37	0.93	0.6	0.87
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	992.35	392.34	606.59	420.55
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	-703.17	-166.74	-325.38	-147.94
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	-14.17	-46.84	-57.09	-63.12
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	15	16	28
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	15	16	28

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	178	129	143	85	3,817	3,045	1,429	3,355	3,769	4,118	9,293
- Cash & Cash Equivalents	2	3	48	37	34	14	220	184	86	201	386	315	323
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	4	- -	10	10	7	20	50	50	95	186	193	218
Enterprise Value	2	2	129	102	119	78	3,617	2,911	1,392	3,249	3,569	3,995	9,188
Total Capital	2	1	46	31	27	8	199	164	65	204	377	250	306
Total Debt/Capital (%)	212.79	350.14	- -	31.11	37.27	88.05	10.03	30.58	76.08	46.36	49.39	77.19	71.18
Total Debt / EV	2.2	2.4	- -	0.1	0.08	0.09	0.01	0.02	0.04	0.03	0.05	0.05	0.02
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	64.93	13.19	10.36	14.39
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	111	129	127	76	3,516	3,031	1,421	3,136	3,615	4,054	9,086
Diluted Enterprise Value	2	2	63	102	103	69	3,316	2,897	1,384	3,030	3,416	3,932	8,981
EV per Share	0.1	0.11	6.76	5.35	4.66	2.59	97.94	77.89	36.81	74.69	75.37	82.1	180.58
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	50	271	386	638
TTM EBITDA	-2	-5	-9	-27	-27	-33	-67	-99	-125	-172	-176	-244	-160
TTM Operating Income	-2	-5	-9	-27	-27	-33	-67	-99	-125	-177	-183	-252	-169
TTM Cash Flow to Firm	-1	-2	-7	-21	-25	-29	-45	-76	-103	-109	-139	-122	-87
TTM Free Cash Flow to Firm	-1	-2	-7	-21	-25	-29	-45	-76	-102	-108	-138	-122	-86

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-14.93	-6.1	-4.82	-2.53	-75.85	-38.66	-13.17	-27.08	-25.02	-31.64	-97.78
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	2	129	102	119	78	3,617	2,911	1,392	3,249	3,569	3,995	9,188
Low Price	- -	- -	8	5.25	3.53	1.94	2.52	35.44	19.38	20.63	53.71	64.11	79.19
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	64.93	13.19	10.36	14.39
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-8.61	-5.8	-3.81	-2.68	-11.97	-28.12	-14.79	-9.39	-13.34	-14.07	-32.1
Price/Earnings High	- -	- -	-9.49	-11.08	-5.58	-5	-54.72	-39.6	-23.94	-17.81	-17.33	-17.52	-50.08
Price/Earnings Low	- -	- -	-7.83	-3.7	-2.78	-1.68	-1.25	-12.81	-5.59	-4.48	-10.2	-10.7	-21.51
Price/Book Value	- -	- -	3.82	5.99	8.54	90.46	21.36	26.76	91.41	30.62	19.73	72.22	105.25
Price/Book Value Average	- -	- -	3.63	7.32	7.39	99.05	4.97	25.54	124.05	17.16	17.42	72	68.1
Price/Book Value High	- -	- -	4	13.98	10.83	184.77	22.72	35.97	200.77	32.56	22.63	89.63	106.27
Price/Book Value Low	- -	- -	3.3	4.66	5.38	62.23	0.52	11.64	46.89	8.19	13.32	54.72	45.64
Price/Tangible Book Value	- -	- -	3.82	5.99	8.54	90.46	21.36	26.76	91.41	84.76	29.99	-2,143.55	260.07
Price/Tangible Book Value Average	- -	- -	3.63	7.32	7.39	99.05	4.97	25.54	124.05	47.48	26.48	-2,136.98	168.28
Price/Tangible Book Value High	- -	- -	4	13.98	10.83	184.77	22.72	35.97	200.77	90.11	34.4	-2,660.12	262.57
Price/Tangible Book Value Low	- -	- -	3.3	4.66	5.38	62.23	0.52	11.64	46.89	22.67	20.24	-1,624.2	112.76
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	62.67	13.36	10.51	14.23
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	35.11	11.8	10.48	9.21
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	66.63	15.32	13.04	14.37
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.76	9.02	7.96	6.17
Price/Cash Flow	- -	- -	-14.89	-6.07	-4.82	-2.52	-75.82	-38.64	-13.13	-26.91	-24.92	-31.57	-97.27
Price/Cash Flow Average	- -	- -	-14.14	-7.41	-4.17	-2.76	-17.64	-36.88	-17.82	-15.08	-22	-31.47	-62.94
Price/Cash Flow High	- -	- -	-15.58	-14.16	-6.11	-5.15	-80.65	-51.94	-28.84	-28.61	-28.58	-39.18	-98.21
Price/Cash Flow Low	- -	- -	-12.85	-4.72	-3.04	-1.74	-1.85	-16.81	-6.74	-7.2	-16.82	-23.92	-42.18
Price/Free Cash Flow Average	- -	- -	-14.17	-7.45	-4.17	-2.77	-17.64	-36.9	-17.87	-15.17	-22.09	-31.54	-63.27
Price/Free Cash Flow High	- -	- -	-15.62	-14.23	-6.11	-5.16	-80.68	-51.97	-28.93	-28.79	-28.7	-39.26	-98.72
Price/Free Cash Flow Low	- -	- -	-12.88	-4.75	-3.04	-1.74	-1.85	-16.82	-6.76	-7.24	-16.88	-23.97	-42.39
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	35.44	11.56	10.33	9.25
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	69.16	15.24	12.93	14.53
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.81	8.66	7.77	6.15
EV/EBITDA Average	-0.94	-0.34	-13.11	-4.84	-3.69	-2.63	-10.26	-28	-15.26	-10.31	-17.76	-16.29	-36.89
EV/EBITDA High	-0.94	-0.34	-14.98	-10.15	-5.83	-5.1	-57.56	-39.99	-24.88	-20.11	-23.42	-20.4	-57.93
EV/EBITDA Low	-0.94	-0.34	-11.44	-2.72	-2.45	-1.57	1.59	-12.03	-5.59	-4.6	-13.31	-12.26	-24.5
EV/EBIT Average	-0.94	-0.34	-13.11	-4.84	-3.69	-2.63	-10.25	-27.98	-15.25	-10.05	-17.1	-15.78	-34.91
EV/EBIT High	-0.94	-0.34	-14.97	-10.15	-5.82	-5.09	-57.53	-39.96	-24.87	-19.61	-22.54	-19.76	-54.82
EV/EBIT Low	-0.94	-0.34	-11.43	-2.72	-2.44	-1.57	1.59	-12.02	-5.58	-4.48	-12.81	-11.87	-23.19
Last Price	- -	- -	9.27	6.75	5.6	2.82	103.36	81.47	37.78	77.13	79.59	84.61	182.64
High Price	- -	- -	9.7	15.74	7.1	5.76	109.94	109.53	82.98	82	91.29	105	184.4
Enterprise Value Average	2	2	121	131	99	86	688	2,772	1,902	1,774	3,128	3,983	5,908
Enterprise Value High	2	2	138	275	157	166	3,860	3,960	3,101	3,461	4,123	4,988	9,278
Enterprise Value Low	2	2	105	74	66	51	-107	1,191	696	791	2,343	2,998	3,925

Shares Outstanding	18	18	19	19	25	30	37	37	38	43	47	49	51
Diluted Weighted Avg Shares	13	13	12	19	23	27	34	37	38	41	45	48	50
Basic Weighted Avg Shares	13	13	12	19	23	27	34	37	38	41	45	48	50
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.23	5.96	8.05	12.83
EBITDA per Share	-0.14	-0.43	-0.77	-1.41	-1.18	-1.21	-1.97	-2.66	-3.31	-4.23	-3.88	-5.1	-3.22
Operating Income per Share	-0.14	-0.43	-0.77	-1.41	-1.18	-1.21	-1.97	-2.66	-3.32	-4.34	-4.03	-5.27	-3.4
Basic EPS, GAAP	-0.17	-0.47	-1.02	-1.42	-1.27	-1.15	-2.01	-2.77	-3.47	-4.6	-5.27	-5.99	-3.68
Basic EPS from Cont Ops	-0.17	-0.47	-1.02	-1.42	-1.27	-1.15	-2.01	-2.77	-3.47	-4.6	-5.27	-5.99	-3.68
Diluted EPS, GAAP	-0.17	-0.47	-1.02	-1.42	-1.27	-1.15	-2.01	-2.77	-3.47	-4.6	-5.27	-5.99	-3.68
Diluted EPS from Cont Ops	-0.17	-0.47	-1.02	-1.42	-1.27	-1.15	-2.01	-2.77	-3.47	-4.6	-5.27	-5.99	-3.68
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.13	-0.36	-0.62	-1.11	-1.16	-1.12	-1.36	-2.11	-2.88	-2.87	-3.19	-2.68	-1.88
Free Cash Flow per Basic Share	-0.13	-0.36	-0.62	-1.12	-1.16	-1.12	-1.36	-2.11	-2.89	-2.88	-3.21	-2.69	-1.89
Cash & Equivalents per Share	0.12	0.15	2.51	1.91	1.33	0.46	5.96	4.92	2.29	4.62	8.16	6.48	6.35
Book Value per Share	-0.11	-0.18	2.43	1.13	0.66	0.03	4.84	3.04	0.41	2.52	4.03	1.17	1.74
Tangible Book Value per Share	-0.11	-0.18	2.43	1.13	0.66	0.03	4.84	3.04	0.41	0.91	2.65	-0.04	0.7

Axsome Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)